Paying users zone. Data is covered by hidden.

  • Get 1-month access to Abbott Laboratories for $19.99, or

  • get full access to entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Abbott Laboratories (ABT)


Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Difficulty: Beginner

Abbott Laboratories, common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Short-term borrowings hidden hidden hidden hidden hidden
Trade accounts payable hidden hidden hidden hidden hidden
Salaries, wages and commissions hidden hidden hidden hidden hidden
Accrued rebates payable to government agencies hidden hidden hidden hidden hidden
Accrued other rebates hidden hidden hidden hidden hidden
All other hidden hidden hidden hidden hidden
Other accrued liabilities hidden hidden hidden hidden hidden
Dividends payable hidden hidden hidden hidden hidden
Income taxes payable hidden hidden hidden hidden hidden
Current portion of long-term debt hidden hidden hidden hidden hidden
Current liabilities held for disposition hidden hidden hidden hidden hidden
Current liabilities hidden hidden hidden hidden hidden
Long-term debt, excluding current portion hidden hidden hidden hidden hidden
Defined benefit pension plans and post-employment medical and dental plans for significant plans hidden hidden hidden hidden hidden
Deferred income taxes hidden hidden hidden hidden hidden
All other hidden hidden hidden hidden hidden
Post-employment obligations and other long-term liabilities hidden hidden hidden hidden hidden
Non-current liabilities held for disposition hidden hidden hidden hidden hidden
Non-current liabilities hidden hidden hidden hidden hidden
Total liabilities hidden hidden hidden hidden hidden
Preferred shares, one dollar par value, none issued hidden hidden hidden hidden hidden
Common shares, without par value hidden hidden hidden hidden hidden
Common shares held in treasury, at cost hidden hidden hidden hidden hidden
Earnings employed in the business hidden hidden hidden hidden hidden
Accumulated other comprehensive loss hidden hidden hidden hidden hidden
Total Abbott shareholders’ investment hidden hidden hidden hidden hidden
Noncontrolling interests in subsidiaries hidden hidden hidden hidden hidden
Total shareholders’ investment hidden hidden hidden hidden hidden
Total liabilities and shareholders’ investment hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Abbott Laboratories’s current liabilities as a percentage of total liabilities and shareholders’ investment declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.
Non-current liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Abbott Laboratories’s non-current liabilities as a percentage of total liabilities and shareholders’ investment declined from 2016 to 2017 and from 2017 to 2018.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Abbott Laboratories’s total liabilities as a percentage of total liabilities and shareholders’ investment declined from 2016 to 2017 and from 2017 to 2018.
Total Abbott shareholders’ investment Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Abbott Laboratories’s total Abbott shareholders’ investment as a percentage of total liabilities and shareholders’ investment increased from 2016 to 2017 and from 2017 to 2018.